Concepedia

Publication | Closed Access

Ruxolitinib for the treatment of inadequately controlled polycythaemia vera without splenomegaly (RESPONSE-2): a randomised, open-label, phase 3b study

245

Citations

26

References

2016

Year

References

YearCitations

Page 1